Beta Wealth Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$972K Buy
6,523
+599
+10% +$84K 0.36% 52
2026
Q2
$748K Buy
5,924
+302
+5% +$39.8K 0.28% 61
2026
Q1
$784K Sell
5,622
-398
-7% -$55.7K 0.32% 52
2025
Q4
$739K Sell
6,020
-198
-3% -$24.1K 0.3% 53
2025
Q3
$690K Buy
6,218
+302
+5% +$34.3K 0.27% 57
2025
Q2
$656K Sell
5,916
-1,612
-21% -$172K 0.24% 51
2025
Q1
$844K Sell
7,528
-95
-1% -$9.8K 0.3% 43
2024
Q4
$704K Buy
7,623
+102
+1% +$9.18K 0.31% 50
2024
Q3
$631K Buy
7,521
+802
+12% +$61.2K 0.28% 60
2024
Q2
$47K Buy
6,719
+193
+3% +$12.9K 0.02% 102
2024
Q1
$478K Buy
6,526
+216
+3% +$16.6K 0.23% 68
2023
Q4
$511K Sell
6,310
-96
-1% -$7.47K 0.27% 60
2023
Q3
$480K Buy
6,406
+105
+2% +$8.08K 0.28% 64
2023
Q2
$486K Buy
6,301
+1,501
+31% +$120K 0.28% 63
2023
Q1
$398K Buy
+4,800
New +$398K 0.23% 66
2022
Q4
– Sell
-4,100
Closed -$252K – 99
2022
Q3
$252K Buy
4,100
+200
+5% +$12.6K 0.18% 77
2022
Q2
$241K Buy
3,900
+300
+8% +$18.6K 0.16% 75
2022
Q1
$214K Buy
+3,600
New +$230K 0.14% 89

Other funds holding GILD

Beta Wealth Group's GILD Position: Q3 2026 in Review

Beta Wealth Group increased its Gilead Sciences (GILD) stake by 10% in Q3 2026, buying an estimated $84K and bringing the position to 6,523 shares worth $972K. The position accounts for 0.36% of the portfolio, ranked #52.

Beta Wealth Group first reported a position in GILD in Q1 2022 and has held it in 18 quarters since. 1,582 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Beta Wealth Group held 6,523 shares of Gilead Sciences worth $972K as of Q3 2026.
  • Beta Wealth Group bought 599 Gilead Sciences shares in Q3 2026, an estimated $84K.
  • Gilead Sciences made up 0.36% of Beta Wealth Group's portfolio in Q3 2026, its #52 holding.
  • Beta Wealth Group first reported a position in Gilead Sciences in Q1 2022 and has held it in 18 quarters since.
  • 1,582 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Beta Wealth Group's 13F filing for Q3 2026, filed 10 Nov 2026.